A Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control
A Randomized, Controlled, Open-label, Multi-center Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control
The benefit of drug therapy to persons with diabetes has been well established in clinical trials in terms of reducing cardiovascular risk, microvascular complications and mortality. However, treatment adherence and treatment effectiveness continue to be challenges in diabetes management.
Rimidi Diabetes has developed software algorithms to simulate the effect of anti-diabetic medications on an individual's glucose profile, allowing the clinician and their patient to visualize the anticipated outcome of a medical intervention. Use of this technology should allow for more targeted decision-making by the clinician and should facilitate a shared decision-making process with the PwD who is now privy to the thought process behind their medical management.
The proposed study is designed to test whether adding a decision support capability (Diabetes+Me Rx) that allows for modeling the anticipated effect of medication adjustments leads to improved glycemic control and a perceived benefit by healthcare providers and PwDs.
연구 개요
상태
정황
상세 설명
Recruitment
- Recruitment of persons with diabetes through a community diabetes management center according to inclusion and exclusion criteria below.
- This is a three-armed study. Enrollees will be randomized to continue diabetes care with standard diabetes management in the Medication Management Clinic or the Intervention Group and compared to a matched cohort managed through their primary care physician (PCP) and standard of care.
- The Intervention Group will be standard diabetes management in the Medication Management Clinic plus the use of Diabetes+Me with a connected glucometer.
- Upon recruitment, PwD will be oriented to the Diabetes+Me application and instructed on how to complete a glucose profile and how to enter data into the application. Baseline hemoglobin A1C will be measured.
- Enrollees will complete a brief survey of satisfaction with their diabetes management.
Study visits
- The first study visit will be 2 weeks following enrollment.
- Weight, number of medications, number of medication titrations, the presence of insulin and blood pressure will be measured at each study visit. Frequency of hypoglycemia in the preceding week will be documented at each visit. Adherence to medical prescription to be documented at each visit.
- If the PwD has not entered data into Diabetes+Me this will be done at the beginning of each study visit.
- At the first study visit, the HCP will review the glucose profile from the previous week, identify areas where the PwD is not meeting targets and model adjustments to their medications to achieve the desired anticipated effect. If indicated, a new prescription will be issued and the PwD instructed to collect a new glucose profile the week preceding the next visit.
- The second study visit will occur 5 weeks following the initial visit. The HCP and PwD will review the glucose profile from the previous week, identify areas where the PwD is not meeting targets and model adjustments to their medications to achieve the desired anticipated effect. If indicated, a new prescription will be issued and the PwD instructed to collect a new glucose profile the week preceding the final visit.
The third and final study visit will occur 5 weeks following the second visit. The HCP and PwD will review the glucose profile from the previous week and identify if the PwD is meeting targets.
연구 유형
등록 (예상)
단계
- 해당 없음
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Physician diagnosis of type 1 or type 2 diabetes
- Glycated hemoglobin > 9% within 3 months
- Age 18-80
- Not currently managed by study clinicians
Exclusion Criteria:
- Pregnant
- Active substance abuse
- Severe hearing or visual impairment
- No internet or email access
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Intervention Group
Patient in standard diabetes management in the Medication Management Clinic plus the use of Diabetes+Me plus connected glucometer
|
referral to medication management clinic from primary care
Use of software and medication modeling tool as add on to medication management standard of care
|
|
활성 비교기: Standard Diabetes Management
Patient in standard diabetes management in the Medication Management Clinic
|
referral to medication management clinic from primary care
|
|
간섭 없음: Primary Care
Matched cohort managed through their primary care physician (PCP) and standard of care.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Hemoglobin A1C
기간: change from baseline to 12 weeks
|
change from baseline to 12 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of hypoglycemic events per week
기간: change from 1st week to twelfth week
|
Decrease in frequency of hypoglycemia (# events per week
|
change from 1st week to twelfth week
|
|
Blood pressure
기간: change from baseline to 12 weeks
|
increase in percentage of patients with blood pressure in normotensive range
|
change from baseline to 12 weeks
|
|
BMI
기간: change from baseline to 12 weeks
|
decrease in BMI
|
change from baseline to 12 weeks
|
|
Healthcare provider satisfaction
기간: through study completion, an average of 1 year
|
healthcare provider satisfaction based on scoring of questionnaire
|
through study completion, an average of 1 year
|
|
A1C target attainment
기간: at 12 weeks
|
time to A1c goal attainment
|
at 12 weeks
|
|
Medication titrations needed
기간: 12 weeks
|
number of medication titrations over 12 week period needed to reach A1c goal
|
12 weeks
|
|
Patient satisfaction questionnaire
기간: through patient study completion, an average of 12 weeks
|
questionnaire addresses satisfaction with care and knowledge of diabetes self-management
|
through patient study completion, an average of 12 weeks
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Michael Jardula, MD, Desert Oasis Healthcare
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Medication Management Clinic에 대한 임상 시험
-
Transitions ClinicUniversity of California, Davis완전한
-
Fondazione Poliambulanza Istituto Ospedaliero알려지지 않은
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and Prevention완전한